Skip to content
TrialScanner

NCT05002231

Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets

Phase 1CompletedFULCLead

Registry record

Lead sponsor
Fulcrum Therapeutics
Conditions
Healthy Adult Subjects
Primary completion
Oct 5, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05002231 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05002231: Relative Bioavailability and... | TrialScanner